DarkIris prices USD 6 million best-efforts public offering of Class A share units and warrants
Bitget2026/10/08 13:25DarkIris priced a best-efforts public offering expected to raise about USD 6 million in gross proceeds. Deal covers 4,166,666 units at USD 1.44 each, or pre-funded units at USD 1.4399. Each unit includes one Class A ordinary share plus one warrant exercisable at USD 2.04, expiring six months post-issuance. Warrants are immediately exercisable, including a zero-cash exercise option exchanging each warrant for about 12 Class A ordinary shares. Net proceeds earmarked for working capital, general corporate purposes; closing targeted for Oct. 9, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Darkiris Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610080925PRIMZONEFULLFEED9842188) on October 08, 2026, and is solely responsible for the information contained therein.
- DarkIris priced a best-efforts public offering expected to raise about USD 6 million in gross proceeds.
- Deal covers 4,166,666 units at USD 1.44 each, or pre-funded units at USD 1.4399.
- Each unit includes one Class A ordinary share plus one warrant exercisable at USD 2.04, expiring six months post-issuance.
- Warrants are immediately exercisable, including a zero-cash exercise option exchanging each warrant for about 12 Class A ordinary shares.
- Net proceeds earmarked for working capital, general corporate purposes; closing targeted for Oct. 9, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Canadian used car dealer UC Automotive (UCAU.RC.US) files for IPO in the US: aims to raise 29 million USD and list on Nasdaq
Canadian used car dealer UC Automotive has applied for a Nasdaq IPO, aiming to raise up to $29 million, with its main focus on the Greater Vancouver market. Kingswood is the sole underwriter.
Crypto prices
More
